Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies

被引:191
|
作者
Lempp, Florian A. [1 ]
Soriaga, Leah B. [1 ]
Montiel-Ruiz, Martin [1 ]
Benigni, Fabio [2 ]
Noack, Julia [1 ]
Park, Young-Jun [3 ]
Bianchi, Siro [2 ]
Walls, Alexandra C. [3 ]
Bowen, John E. [3 ]
Zhou, Jiayi [1 ]
Kaiser, Hannah [1 ]
Joshi, Anshu [3 ]
Agostini, Maria [1 ]
Meury, Marcel [1 ]
Dellota, Exequiel, Jr. [1 ]
Jaconi, Stefano [2 ]
Cameroni, Elisabetta [2 ]
Martinez-Picado, Javier [4 ,5 ,6 ]
Vergara-Alert, Julia [7 ]
Izquierdo-Useros, Nuria [4 ,8 ]
Virgin, Herbert W. [9 ,10 ]
Lanzavecchia, Antonio [2 ]
Veesler, David [3 ]
Purcell, Lisa A. [11 ]
Telenti, Amalio [1 ]
Corti, Davide [1 ]
机构
[1] Vir Biotechnol, San Francisco, CA 94158 USA
[2] Humabs Biomed SA, Bellinzona, Switzerland
[3] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
[4] IrsiCaixa AIDS Res Inst, Badalona, Spain
[5] Univ Vic Cent Univ Catalonia UVic UCC, Vic, Spain
[6] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain
[7] IRTA UAB, IRTA, Ctr Recerca Sanitat Anim CReSA, Campus UAB, Bellaterra, Cerdanyola Del, Spain
[8] Germans Trias & Pujol Res Inst IGTP, Can Ruti Campus, Badalona, Spain
[9] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA
[10] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA
[11] Vir Biotechnol, St Louis, MO USA
关键词
RECEPTOR-BINDING DOMAIN; CELLS;
D O I
10.1038/s41586-021-03925-1
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
SARS-CoV-2 infection-which involves both cell attachment and membrane fusion-relies on the angiotensin-converting enzyme 2 (ACE2) receptor, which is paradoxically found at low levels in the respiratory tract(1-3), suggesting that there may be additional mechanisms facilitating infection. Here we show that C-type lectin receptors, DC-SIGN, L-SIGN and the sialic acid-binding immunoglobulin-like lectin 1 (SIGLEC1) function as attachment receptors by enhancing ACE2-mediated infection and modulating the neutralizing activity of different classes of spike-specific antibodies. Antibodies to the amino-terminal domain or to the conserved site at the base of the receptor-binding domain, while poorly neutralizing infection of ACE2-overexpressing cells, effectively block lectin-facilitated infection. Conversely, antibodies to the receptor binding motif, while potently neutralizing infection of ACE2-overexpressing cells, poorly neutralize infection of cells expressing DC-SIGN or L-SIGN and trigger fusogenic rearrangement of the spike, promoting cell-to-cell fusion. Collectively, these findings identify a lectin-dependent pathway that enhances ACE2-dependent infection by SARS-CoV-2 and reveal distinct mechanisms of neutralization by different classes of spike-specific antibodies.
引用
收藏
页码:342 / +
页数:24
相关论文
共 50 条
  • [31] Neutralizing antibodies targeting SARS-CoV-2 spike protein
    Shi Xiaojie
    Li Yu
    Yan Lei
    Yang Guang
    Qiang Min
    [J]. STEM CELL RESEARCH, 2021, 50
  • [32] Duration of SARS-CoV-2 Serum-Neutralizing Antibodies Against SARS-CoV-2 Dependent on the Individual
    Li, Jin
    Zou, Li
    Li, Shaojie
    Zou, Ruogu
    Fang, Zhixiong
    Zhang, Pingan
    Li, Huijun
    Wang, Shanshan
    Ke, Dong
    Gao, Peng
    Jin, Cuicui
    Fang, Cong
    Zhou, Ji
    He, Ellen
    Skog, Sven
    [J]. VIRAL IMMUNOLOGY, 2023, 36 (03) : 153 - 162
  • [33] Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
    Imbrechts, Maya
    Maes, Wim
    Ampofo, Louanne
    Van den Berghe, Nathalie
    Calcoen, Bas
    Van Looveren, Dominique
    Kerstens, Winnie
    Rasulova, Madina
    Vercruysse, Thomas
    Noppen, Sam
    Abdelnabi, Rana
    Foo, Caroline
    Hollevoet, Kevin
    Maes, Piet
    Zhang, Xin
    Jochmans, Dirk
    Ven, Karen
    Lammertyn, Jeroen
    Vanhoorelbeke, Karen
    Callewaert, Nico
    De Munter, Paul
    Schols, Dominique
    Thibaut, Hendrik Jan
    Neyts, Johan
    Declerck, Paul
    Geukens, Nick
    [J]. ISCIENCE, 2022, 25 (08)
  • [34] Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
    Epaulard, Olivier
    Buisson, Marlyse
    Nemoz, Benjamin
    Le Marechal, Marion
    Terzi, Nicolas
    Payen, Jean-Francois
    Froidure, Marie
    Blanc, Myriam
    Mounayar, Anne-Laure
    Quenard, Fanny
    Pierre, Isabelle
    Pavese, Patricia
    Germi, Raphaele
    Grossi, Laurence
    Larrat, Sylvie
    Poignard, Pascal
    Lupo, Julien
    [J]. JOURNAL OF INFECTION, 2022, 84 (03) : 462 - 465
  • [35] Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion
    Li, Chia-Jung
    Chao, Tai-Ling
    Chang, Ting-Yu
    Hsiao, Chia-Chun
    Lu, De-Chao
    Chiang, Yi-Wei
    Lai, Guan-Chun
    Tsai, Ya-Min
    Fang, Jun-Tung
    Ieong, Siman
    Wang, Jann-Tay
    Chang, Sui-Yuan
    Chang, Shih-Chung
    [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (02):
  • [36] Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection
    Tan, Yun
    Liu, Feng
    Xu, Xiaoguang
    Ling, Yun
    Huang, Weijin
    Zhu, Zhaoqin
    Guo, Mingquan
    Lin, Yixiao
    Fu, Ziyu
    Liang, Dongguo
    Zhang, Tengfei
    Fan, Jian
    Xu, Miao
    Lu, Hongzhou
    Chen, Saijuan
    [J]. FRONTIERS OF MEDICINE, 2020, 14 (06) : 746 - 751
  • [37] A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques
    Cobb, Ronald R.
    Nkolola, Joseph
    Gilchuk, Pavlo
    Chandrashekar, Abishek
    Yu, Jingyou
    House, Robert, V
    Earnhart, Christopher G.
    Dorsey, Nicole M.
    Hopkins, Svetlana A.
    Snow, Doris M.
    Chen, Rita E.
    VanBlargan, Laura A.
    Hechenblaickner, Manuel
    Hoppe, Brian
    Collins, Laura
    Tomic, Milan T.
    Nonet, Genevieve H.
    Hackett, Kyal
    Slaughter, James C.
    Lewis, Mark G.
    Andersen, Hanne
    Cook, Anthony
    Diamond, Michael S.
    Carnahan, Robert H.
    Barouch, Dan H.
    Crowe, James E., Jr.
    [J]. MED, 2022, 3 (03): : 188 - +
  • [38] Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection
    Yun Tan
    Feng Liu
    Xiaoguang Xu
    Yun Ling
    Weijin Huang
    Zhaoqin Zhu
    Mingquan Guo
    Yixiao Lin
    Ziyu Fu
    Dongguo Liang
    Tengfei Zhang
    Jian Fan
    Miao Xu
    Hongzhou Lu
    Saijuan Chen
    [J]. Frontiers of Medicine, 2020, 14 : 746 - 751
  • [39] Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies
    Zhou, Dongyan
    Chan, Jasper Fuk-Woo
    Zhou, Biao
    Zhou, Runhong
    Li, Shuang
    Shan, Sisi
    Liu, Li
    Zhang, Anna Jinxia
    Chen, Serena J.
    Chan, Chris Chung-Sing
    Xu, Haoran
    Poon, Vincent Kwok-Man
    Yuan, Shuofeng
    Li, Cun
    Chik, Kenn Ka-Heng
    Chan, Chris Chun-Yiu
    Cao, Jianli
    Chan, Chun-Yin
    Kwan, Ka-Yi
    Du, Zhenglong
    Lau, Thomas Tsz-Kan
    Zhang, Qi
    Zhou, Jie
    To, Kelvin Kai-Wang
    Zhang, Linqi
    Ho, David D.
    Yuen, Kwok-Yung
    Chen, Zhiwei
    [J]. CELL HOST & MICROBE, 2021, 29 (04) : 551 - +
  • [40] Phosphatidylserine receptors enhance SARS-CoV-2 infection
    Bohan, Dana
    Van Ert, Hanora
    Ruggio, Natalie
    Rogers, Kai J.
    Badreddine, Mohammad
    Briseno, Jose A. Aguilar
    Elliff, Jonah M.
    Chavez, Roberth Anthony Rojas
    Gao, Boning
    Stokowy, Tomasz
    Christakou, Eleni
    Kursula, Petri
    Micklem, David
    Gausdal, Gro
    Haim, Hillel
    Minna, John
    Lorens, James B.
    Maury, Wendy
    [J]. PLOS PATHOGENS, 2021, 17 (11)